ARCHIVES

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

DRCCA Board, Subcommittee Approve Reorganization Of Education Program

February 5, 1982

In Brief: Sparano Named Vice Chair of ECOG-ACRIN

May 17, 2013

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002